Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Ferrarotto

Showing results (91-100 of 213) with videos related to

Pageof 22
Sort By:
Head & Neck|December 28, 2023
Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitorsCielito C Reyes-Gibby, Aiham Qdaisat, Renata Ferrarotto, et al.
Cancers|September 2, 2020
Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell CarcinomaDavid Y Lee, Kathryn J Brayer, Yoshitsugu Mitani, et al.
The Laryngoscope|December 12, 2017
Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulbAshley C Mays, Diana Bell, Renata Ferrarotto, et al.
Head & Neck|October 19, 2023
Sinonasal NUT carcinoma: A consecutive case series and systematic reviewUma Ramesh, Kevin J Contrera, Nasim Shakibai, et al.
Head & Neck|June 1, 2017
Outcomes for olfactory neuroblastoma treated with induction chemotherapyShirley Y Su, Diana Bell, Renata Ferrarotto, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2018
Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid CarcinomaMaria E Cabanillas, Renata Ferrarotto, Adam S Garden, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2023
Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal CarcinomaKevin J Contrera, Nasim Shakibai, Shirley Y Su, et al.
Oral Oncology|December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion studyRenata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.
The Journal of Pathology|August 11, 2023
Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkersMarta Persson, Mattias K Andersson, Per-Erik Sahlin, et al.
Pageof 22

Showing results (91-100 of 213) with videos related to

Sort By:
Pageof 22
Head & Neck|December 28, 2023
Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitorsCielito C Reyes-Gibby, Aiham Qdaisat, Renata Ferrarotto, et al.
Cancers|September 2, 2020
Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell CarcinomaDavid Y Lee, Kathryn J Brayer, Yoshitsugu Mitani, et al.
The Laryngoscope|December 12, 2017
Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulbAshley C Mays, Diana Bell, Renata Ferrarotto, et al.
Head & Neck|October 19, 2023
Sinonasal NUT carcinoma: A consecutive case series and systematic reviewUma Ramesh, Kevin J Contrera, Nasim Shakibai, et al.
Head & Neck|June 1, 2017
Outcomes for olfactory neuroblastoma treated with induction chemotherapyShirley Y Su, Diana Bell, Renata Ferrarotto, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2018
Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid CarcinomaMaria E Cabanillas, Renata Ferrarotto, Adam S Garden, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2023
Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal CarcinomaKevin J Contrera, Nasim Shakibai, Shirley Y Su, et al.
Oral Oncology|December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion studyRenata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.
The Journal of Pathology|August 11, 2023
Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkersMarta Persson, Mattias K Andersson, Per-Erik Sahlin, et al.
Pageof 22